Advances in the understanding of the pathophysiology and management of aortic stenosis: Role of novel imaging techniques

Canadian Journal of Cardiology

Volumn 30, Issue 9, 2014, Pages 994-1003

  Singh, Anvesha ^a,b   Steadman, Christopher D ^c   McCann, Gerry P ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

AORTA STENOSIS; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDITIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DISEASE ACTIVITY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; IN VIVO STUDY; NONHUMAN; NYOCARDIAL STEATOSIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; STEATOSIS; TISSUE CHARACTERIZATION;

AORTIC VALVE STENOSIS; CARDIAC IMAGING TECHNIQUES; ECHOCARDIOGRAPHY; EXERCISE; HUMANS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; SPECTRUM ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906317267     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.008     Document Type: Review

References (71)

1. Bridgewater B, Kinsman R, Walton P, Keogh B. Demonstrating quality: the sixth national adult cardiac surgery database report. Henley-on-Thames: Society for Cardiothoracic Surgery in Great Britain & Ireland,2008.
2. Pai R.G., Kapoor N., Bansal R.C., Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006, 82:2116-2122.
3. Bonow R.O., Carabello B.A., Chatterjee K., et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. JAm Coll Cardiol 2008, 52:e1-142.
4. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007, 28:230-268.
5. Shah P.K. Severe aortic stenosis should not be operated on before symptom onset. Circulation 2012, 126:118-125.
6. Carabello B.A. Aortic valve replacement should be operated on before symptom onset. Circulation 2012, 126:112-117.
7. Iung B., Baron G., Butchart E.G., et al. Aprospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231-1243.
8. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. NEngl J Med 2000, 343:611-617.
9. Rosenhek R., Zilberszac R., Schemper M., et al. Natural history of very severe aortic stenosis. Circulation 2010, 121:151-156.
10. Das P., Rimington H., Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005, 26:1309-1313.
11. Steadman C.D., Ray S., Ng L.L., McCann G.P. Natriuretic peptides in common valvular heart disease. JAm Coll Cardiol 2010, 55:2034-2048.
12. Alborino D., Hoffmann J.L., Fournet P.C., Bloch A. Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. JHeart Valve Dis 2002, 11:204-209.
13. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012, 33:2451-2496.
14. Pibarot P., Dumesnil J.G. Improving assessment of aortic stenosis. JAm Coll Cardiol 2012, 60:169-180.
15. Dweck M.R., Joshi S., Murigu T., et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. JCardiovasc Magn Reson 2012, 14:50.
16. Carabello B.A. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease. JHeart Valve Dis 1995, 4(suppl 2):S132-S138. [discussion: S138-9].
17. Kupari M., Turto H., Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?. Eur Heart J 2005, 26:1790-1796.
18. Esposito G., Rapacciuolo A., Naga Prasad S.V., et al. Genetic alterations that inhibit invivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 2002, 105:85-92.
19. Hess O.M., Ritter M., Schneider J., et al. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984, 69:855-865.
20. Trenouth R.S., Phelps N.C., Neill W.A. Determinants of left ventricular hypertrophy and oxygen supply in chronic aortic valve disease. Circulation 1976, 53:644-650.
21. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003, 107:984-991.
22. Galiuto L., Lotrionte M., Crea F., et al. Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study. Heart 2006, 92:208-212.
23. McCann G.P., Steadman C.D., Ray S.G., Newby D.E. Managing the asymptomatic patient with severe aortic stenosis: randomised controlled trials of early surgery are overdue. Heart 2011, 97:1119-1121.
24. Lancellotti P., Karsera D., Tumminello G., Lebois F., Pierard L.A. Determinants of an abnormal response to exercise in patients with asymptomatic valvular aortic stenosis. Eur J Echocardiogr 2008, 9:338-343.
25. Marechaux S., Hachicha Z., Bellouin A., et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010, 31:1390-1397.
26. Lancellotti P., Magne J., Pierard L.A. The role of stress testing in evaluation of asymptomatic patients with aortic stenosis. Curr Opin Cardiol 2013, 28:531-539.
27. Bruch C., Stypmann J., Grude M., et al. Tissue Doppler imaging in patients with moderate to severe aortic valve stenosis: clinical usefulness and diagnostic accuracy. Am Heart J 2004, 148:696-702.
28. Wang B., Chen H., Shu X., et al. Emerging role of echocardiographic strain/strain rate imaging and twist in systolic function evaluation and operative procedure in patients with aortic stenosis. Interact Cardiovasc Thorac Surg 2013, 17:384-391.
29. Marechaux S., Carpentier E., Six-Carpentier M., et al. Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Arch Cardiovasc Dis 2010, 103:227-235.
30. Ng A.C., Delgado V., Bertini M., et al. Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: a two-dimensional speckle tracking analysis. Eur Heart J 2011, 32:1542-1550.
31. Lafitte S., Perlant M., Reant P., et al. Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 2009, 10:414-419.
32. Yingchoncharoen T., Gibby C., Rodriguez L.L., Grimm R.A., Marwick T.H. Association of myocardial deformation with outcome in asymptomatic aortic stenosis with normal ejection fraction. Circ Cardiovasc Imaging 2012, 5:719-725.
33. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. JAm Coll Cardiol 1990, 15:827-832.
34. Messika-Zeitoun D., Aubry M.C., Detaint D., et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004, 110:356-362.
35. Koos R., Mahnken A.H., Kuhl H.P., et al. Quantification of aortic valve calcification using multislice spiral computed tomography: comparison with atomic absorption spectroscopy. Invest Radiol 2006, 41:485-489.
36. Koos R., Mahnken A.H., Sinha A.M., et al. Aortic valve calcification as a marker for aortic stenosis severity: assessment on 16-MDCT. AJR Am J Roentgenol 2004, 183:1813-1818.
37. Clavel M.A., Messika-Zeitoun D., Pibarot P., et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. JAm Coll Cardiol 2013, 62:2329-2338.
38. Utsunomiya H., Yamamoto H., Kitagawa T., et al. Incremental prognostic value of cardiac computed tomography angiography in asymptomatic aortic stenosis: significance of aortic valve calcium score. Int J Cardiol 2013, 168:5205-5211.
39. Marie-Annick C., Pibarot P., Messika-Zeitoun D., et al. Impact of aortic valve calcification measured by multidetector CT on the outcome of patients with aortic stenosis. JAm Coll Cardiol 2013, 61:E1944.
40. Role of active valvular calcification and inflammation in patients with aortic stenosis. Available at:. Accessed December 12,2013. http://clinicaltrials.gov/ct2/show/NCT01358513?term=NCT01358513%26rank=1.
41. Microvascular Dysfunction in Aortic Stenosis (PRIMID-AS). Available at:. Accessed December 12,2013. http://clinicaltrials.gov/ct2/show/NCT01658345?term=NCT01658345%26rank=1.
42. Cowell S.J., Newby D.E., Prescott R.J., et al. Arandomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. NEngl J Med 2005, 352:2389-2397.
43. Dweck M.R., Joshi N.V., Rudd J.H., Newby D.E. Imaging of inflammation and calcification in aortic stenosis. Curr Cardiol Rep 2013, 15:320.
44. Marincheva-Savcheva G., Subramanian S., Qadir S., et al. Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis. JAm Coll Cardiol 2011, 57:2507-2515.
45. Dweck M.R., Jones C., Joshi N.V., et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012, 125:76-86.
46. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
47. Childs H., Ma L., Ma M., et al. Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation. JCardiovasc Magn Reson 2011, 13:40.
48. John A.S., Dill T., Brandt R.R., et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards?. JAm Coll Cardiol 2003, 42:519-526.
49. Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. JAm Coll Cardiol 2011, 57:891-903.
50. Krayenbuehl H.P., Hess O.M., Monrad E.S., et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989, 79:744-755.
51. Flett A.S., Hayward M.P., Ashworth M.T., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010, 122:138-144.
52. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. JAm Coll Cardiol 2004, 43:2260-2264.
53. Azevedo C.F., Nigri M., Higuchi M.L., et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. JAm Coll Cardiol 2010, 56:278-287.
54. Debl K., Djavidani B., Buchner S., et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 2006, 92:1447-1451.
55. Weidemann F., Herrmann S., Stork S., et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120:577-584.
56. Dweck M.R., Joshi S., Murigu T., et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. JAm Coll Cardiol 2011, 58:1271-1279.
57. Ugander M., Oki A.J., Hsu L.Y., et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012, 33:1268-1278.
58. White S.K., Sado D.M., Fontana M., et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013, 6:955-962.
59. Bull S., White S.K., Piechnik S.K., et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013, 99:932-937.
60. Sado D.M., Flett A.S., Banypersad S.M., et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012, 98:1436-1441.
61. Chin C.W., Semple S., Malley T., et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014, 15:556-565.
62. Flett A.S., Sado D.M., Quarta G., et al. Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 2012, 13:819-826.
63. Hess O.M., Villari B., Krayenbuehl H.P. Diastolic dysfunction in aortic stenosis. Circulation 1993, 87:IV73-IV76.
64. Moon J.C., Messroghli D.R., Kellman P., et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. JCardiovasc Magn Reson 2013, 15:92.
65. Mahmod M., Bull S., Suttie J.J., et al. Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis. Circ Cardiovasc Imaging 2013, 6:808-816.
66. Brindley D.N., Kok B.P., Kienesberger P.C., Lehner R., Dyck J.R. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2010, 298:E897-E908.
67. Garcia D., Camici P.G., Durand L.G., et al. Impairment of coronary flow reserve in aortic stenosis. JAppl Physiol 2009, 106:113-121.
68. Rajappan K., Rimoldi O.E., Dutka D.P., et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002, 105:470-476.
69. Rajappan K., Rimoldi O.E., Camici P.G., et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 2003, 107:3170-3175.
70. Steadman C.D., Jerosch-Herold M., Grundy B., et al. Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc Imaging 2012, 5:182-189.
71. Angiogenesis and fibrosis in aortic stenosis. Available at:. Accessed December 12, 2013. http://clinicaltrials.gov/ct2/show/NCT01837160.